PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26180199 ↗2015Reported benefit

Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.

MouseSpinal cord injuryContusionAfter spinal cord injury (exact timing not stated in the abstract)

Model: Spinal cord contusion injury in mice, complemented by intraspinal injection of lysophosphatidic acid into the normal spinal cord

Lysophosphatidic acid levels increased in contused spinal cord parenchyma during the first 14 days, and intraspinal lysophosphatidic acid injection induced microglia/macrophage activation and demyelination. Selective LPA1 antagonism, or genetic loss of LPA1, linked receptor signalling to demyelinat…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.